{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T16:36:00Z","timestamp":1767544560409,"version":"3.48.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,4]]},"DOI":"10.7759\/cureus.100747","type":"journal-article","created":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T16:33:37Z","timestamp":1767544417000},"source":"Crossref","is-referenced-by-count":0,"title":["Refractory Kawasaki Disease With a Coronary Artery Aneurysm in a Three-Month-Old Infant: Diagnostic Challenges and Rescue With Infliximab"],"prefix":"10.7759","author":[{"given":"Diyar H","family":"Nernji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emad","family":"Elhuni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruqaiya","family":"Al Jashmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahlam","family":"Atiq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000484","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association","volume":"135","author":"McCrindle BW","year":"2017","unstructured":"McCrindle BW, Rowley AH, Newburger JW, et al.. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017, 135:e927-99. 10.1161\/CIR.0000000000000484","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000002982","article-title":"Kawasaki disease and Kawasaki disease shock syndrome hospitalization rates in the United States, 2006-2018","volume":"40","author":"Maddox RA","year":"2021","unstructured":"Maddox RA, Person MK, Kennedy JL, et al.. Kawasaki disease and Kawasaki disease shock syndrome hospitalization rates in the United States, 2006-2018. Pediatr Infect Dis J. 2021, 40:284-8. 10.1097\/INF.0000000000002982","journal-title":"Pediatr Infect Dis J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-0815","article-title":"Delayed diagnosis of Kawasaki disease: what are the risk factors?","volume":"120","author":"Minich LL","year":"2007","unstructured":"Minich LL, Sleeper LA, Atz AM, et al.. Delayed diagnosis of Kawasaki disease: what are the risk factors?. Pediatrics. 2007, 120:e1434-40. 10.1542\/peds.2007-0815","journal-title":"Pediatrics"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2004-2182","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association","volume":"114","author":"Newburger JW","year":"2004","unstructured":"Newburger JW, Takahashi M, Gerber MA, et al.. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics. 2004, 114:1708-33. 10.1542\/peds.2004-2182","journal-title":"Pediatrics"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2018-314967","article-title":"Coronary artery aneurysms are more severe in infants than in older children with Kawasaki disease","volume":"104","author":"Cameron SA","year":"2019","unstructured":"Cameron SA, Carr M, Pahl E, DeMarais N, Shulman ST, Rowley AH. Coronary artery aneurysms are more severe in infants than in older children with Kawasaki disease. Arch Dis Child. 2019, 104:451-5. 10.1136\/archdischild-2018-314967","journal-title":"Arch Dis Child"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2017.03.025","article-title":"High risk of coronary artery aneurysms in infants younger than 6 months of age with Kawasaki disease","volume":"185","author":"Salgado AP","year":"2017","unstructured":"Salgado AP, Ashouri N, Berry EK, Sun X, Jain S, Burns JC, Tremoulet AH. High risk of coronary artery aneurysms in infants younger than 6 months of age with Kawasaki disease. J Pediatr. 2017, 185:112-116.e1. 10.1016\/j.jpeds.2017.03.025","journal-title":"J Pediatr"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2020.00384","article-title":"Presentation and outcomes of Kawasaki disease in Latin American infants younger than 6 months of age: a multinational multicenter study of the REKAMLATINA network","volume":"8","author":"Moreno E","year":"2020","unstructured":"Moreno E, Garcia SD, Bainto E, et al.. Presentation and outcomes of Kawasaki disease in Latin American infants younger than 6 months of age: a multinational multicenter study of the REKAMLATINA network. Front Pediatr. 2020, 8:384. 10.3389\/fped.2020.00384","journal-title":"Front Pediatr"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.011319","article-title":"Risk model development and validation for prediction of coronary artery aneurysms in Kawasaki disease in a North American population","volume":"8","author":"Son MB","year":"2019","unstructured":"Son MB, Gauvreau K, Tremoulet AH, et al.. Risk model development and validation for prediction of coronary artery aneurysms in Kawasaki disease in a North American population. J Am Heart Assoc. 2019, 8:e011319. 10.1161\/JAHA.118.011319","journal-title":"J Am Heart Assoc"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62298-9","article-title":"Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial","volume":"383","author":"Tremoulet AH","year":"2014","unstructured":"Tremoulet AH, Jain S, Jaggi P, et al.. Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial. Lancet. 2014, 383:1731-8. 10.1016\/S0140-6736(13)62298-9","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-014-0102-6","article-title":"Global gene expression profiling identifies new therapeutic targets in acute Kawasaki disease","volume":"6","author":"Hoang LT","year":"2014","unstructured":"Hoang LT, Shimizu C, Ling L, et al.. Global gene expression profiling identifies new therapeutic targets in acute Kawasaki disease. Genome Med. 2014, 6:541. 10.1186\/s13073-014-0102-6","journal-title":"Genome Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2010.10.004","article-title":"New equations and a critical appraisal of coronary artery Z scores in healthy children","volume":"24","author":"Dallaire F","year":"2011","unstructured":"Dallaire F, Dahdah N. New equations and a critical appraisal of coronary artery Z scores in healthy children. J Am Soc Echocardiogr. 2011, 24:60-74. 10.1016\/j.echo.2010.10.004","journal-title":"J Am Soc Echocardiogr"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-200x.2005.02033.x","article-title":"Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition)","volume":"47","author":"Ayusawa M","year":"2005","unstructured":"Ayusawa M, Sonobe T, Uemura S, et al.. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int. 2005, 47:232-4. 10.1111\/j.1442-200x.2005.02033.x","journal-title":"Pediatr Int"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2017.01.068","article-title":"Factors associated with development of coronary artery aneurysms after Kawasaki disease are similar for those treated promptly and those with delayed or no treatment","volume":"236","author":"Downie ML","year":"2017","unstructured":"Downie ML, Manlhiot C, Collins TH, Chahal N, Yeung RS, McCrindle BW. Factors associated with development of coronary artery aneurysms after Kawasaki disease are similar for those treated promptly and those with delayed or no treatment. Int J Cardiol. 2017, 236:157-61. 10.1016\/j.ijcard.2017.01.068","journal-title":"Int J Cardiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4070\/kcj.2016.46.4.550","article-title":"Clinical characteristics of Kawasaki disease in infants younger than six months: a single-center study","volume":"46","author":"Yoon YM","year":"2016","unstructured":"Yoon YM, Yun HW, Kim SH. Clinical characteristics of Kawasaki disease in infants younger than six months: a single-center study. Korean Circ J. 2016, 46:550-5. 10.4070\/kcj.2016.46.4.550","journal-title":"Korean Circ J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000891","article-title":"Patterns of fever in children after primary treatment for Kawasaki disease","volume":"34","author":"Jaggi P","year":"2015","unstructured":"Jaggi P, Wang W, Dvorchik I, et al.. Patterns of fever in children after primary treatment for Kawasaki disease. Pediatr Infect Dis J. 2015, 34:1315-8. 10.1097\/INF.0000000000000891","journal-title":"Pediatr Infect Dis J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-006-0251-8","article-title":"Predictive risk factors for coronary artery abnormalities in Kawasaki disease","volume":"166","author":"Kim T","year":"2007","unstructured":"Kim T, Choi W, Woo CW, et al.. Predictive risk factors for coronary artery abnormalities in Kawasaki disease. Eur J Pediatr. 2007, 166:421-5. 10.1007\/s00431-006-0251-8","journal-title":"Eur J Pediatr"},{"key":"ref17","article-title":"Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children [article in Japanese]","volume":"16","author":"Kawasaki T","year":"1967","unstructured":"Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children [article in Japanese]. Arerugi. 1967, 16:178-222.","journal-title":"Arerugi"},{"key":"ref18","article-title":"Could the increasing concerns regarding the post-COVID-19 symptoms cause Kawasaki disease to be under-diagnosed?","volume":"39 Suppl 128","author":"Haslak F","year":"2021","unstructured":"Haslak F, Karagozlu F, Yildiz M, Adrovic A, Dedeoglu R, Kasapcopur O. Could the increasing concerns regarding the post-COVID-19 symptoms cause Kawasaki disease to be under-diagnosed?. Clin Exp Rheumatol. 2021, 39 Suppl 128:21-2.","journal-title":"Clin Exp Rheumatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-3341","article-title":"Treatment intensification in patients with Kawasaki disease and coronary aneurysm at diagnosis","volume":"143","author":"Dionne A","year":"2019","unstructured":"Dionne A, Burns JC, Dahdah N, et al.. Treatment intensification in patients with Kawasaki disease and coronary aneurysm at diagnosis. Pediatrics. 2019, 143:e20183341. 10.1542\/peds.2018-3341","journal-title":"Pediatrics"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2014.01.020","article-title":"Infliximab plus plasma exchange rescue therapy in Kawasaki disease","volume":"164","author":"Sonoda K","year":"2014","unstructured":"Sonoda K, Mori M, Hokosaki T, Yokota S. Infliximab plus plasma exchange rescue therapy in Kawasaki disease. J Pediatr. 2014, 164:1128-1132.e1. 10.1016\/j.jpeds.2014.01.020","journal-title":"J Pediatr"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2017.10.013","article-title":"Infliximab for the treatment of refractory Kawasaki disease: a nationwide survey in Japan","volume":"195","author":"Masuda H","year":"2018","unstructured":"Masuda H, Kobayashi T, Hachiya A, et al.. Infliximab for the treatment of refractory Kawasaki disease: a nationwide survey in Japan. J Pediatr. 2018, 195:115-120.e3. 10.1016\/j.jpeds.2017.10.013","journal-title":"J Pediatr"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012448.pub2","article-title":"TNF-\u03b1 blockers for the treatment of Kawasaki disease in children","volume":"8","author":"Yamaji N","year":"2019","unstructured":"Yamaji N, da Silva Lopes K, Shoda T, Ishitsuka K, Kobayashi T, Ota E, Mori R. TNF-\u03b1 blockers for the treatment of Kawasaki disease in children. Cochrane Database Syst Rev. 2019, 8:CD012448. 10.1002\/14651858.CD012448.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.5152\/TurkArchPediatr.2025.24248","article-title":"Pharmacoeconomic analysis and considerations for the management of Kawasaki disease in the Arab countries - a multinational, multi-institutional project of the Kawasaki Disease Arab Initiative (Kawarabi) (A project methodology paper)","volume":"60","author":"Nait-Ladjemil D","year":"2025","unstructured":"Nait-Ladjemil D, Harahsheh AS, Choueiter N, et al.. Pharmacoeconomic analysis and considerations for the management of Kawasaki disease in the Arab countries - a multinational, multi-institutional project of the Kawasaki Disease Arab Initiative (Kawarabi) (A project methodology paper). Turk Arch Pediatr. 2025, 60:172-81. 10.5152\/TurkArchPediatr.2025.24248","journal-title":"Turk Arch Pediatr"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/449011-refractory-kawasaki-disease-with-a-coronary-artery-aneurysm-in-a-three-month-old-infant-diagnostic-challenges-and-rescue-with-infliximab","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T16:33:38Z","timestamp":1767544418000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/449011-refractory-kawasaki-disease-with-a-coronary-artery-aneurysm-in-a-three-month-old-infant-diagnostic-challenges-and-rescue-with-infliximab"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,4]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.100747","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,4]]}}}